Clin Sci (Lond) (2018) 132 (1): 85–91.
Endothelin type B (ETB) receptors: friend or foe in the pathogenesis of pre-eclampsia and future cardiovascular disease (CVD) risk?
Clin Sci (Lond) (2018) 132 (1): 33–36.
Clin Sci (Lond) (2018) 132 (1): 127–130.
Hypertrophied myocardium is vulnerable to ischemia/reperfusion injury and refractory to rapamycin-induced protection due to increased oxidative/nitrative stress
Lei-Lei Ma; Yang Li; Pei-Pei Yin; Fei-Juan Kong; Jun-Jie Guo; Hong-Tao Shi; Jian-Bing Zhu; Yun-Zeng Zou; Jun-Bo Ge
Clin Sci (Lond) (2018) 132 (1): 93–110.
Vascular dysfunction in the stroke-prone spontaneously hypertensive rat is dependent on constrictor prostanoid activity and Y chromosome lineage
Shanzana I. Khan; Karen L. Andrews; Ann-Maree Jefferis; Garry L. Jennings; Amanda K. Sampson; Jaye P.F. Chin-Dusting
Clin Sci (Lond) (2018) 132 (1): 131–143.
Clin Sci (Lond) (2018) 132 (1): 157–171.
Cover ImageOleic-acid-treated HepG2 cells immunostained for PGC-1α (PPARγ co-activator-1 α). In Clinical Science volume 132, issue 1, the results of work by Bernardi et al. include reporting that the protein TRAIL (TNF-related apoptosis inducing ligand) increases the expression of PGC-1α in HepG2 cells cultured with oleic acid. Overall, the article points to a potential therapeutic role for TRAIL against impaired glucose tolerance and non-alcoholic fatty liver disease; for details see pages 69–83.